Zydus Lifesciences Gets USFDA Approval for Generic Cancer Treatment
By Rediff Money Desk, NEWDELHI Dec 14, 2023 15:34
Zydus Lifesciences receives USFDA approval for its generic version of Cyclophosphamide capsules, a chemotherapy drug used to treat various cancers. The drug will be manufactured in Ahmedabad, India.
New Delhi, Dec 14 (PTI) Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulatory for its generic version of cancer treatment drug Cyclophosphamide capsules.
The approval by the US Food and Drug Administration (USFDA) is for Cyclophosphamide capsules of strengths 25 mg and 50 mg, Zydus Lifesciences said in a regulatory filing.
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India, it added.
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cells. It treats lymphoma, myeloma, leukemia, breast cancer and ovarian cancer, the company said.
Cyclophosphamide Capsules 25 mg and 50 mg had annual sales of USD 6 million in the US, Zydus Lifesciences said citing IQVIA MAT (moving annual total) October, 2023 data.
The approval by the US Food and Drug Administration (USFDA) is for Cyclophosphamide capsules of strengths 25 mg and 50 mg, Zydus Lifesciences said in a regulatory filing.
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India, it added.
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cells. It treats lymphoma, myeloma, leukemia, breast cancer and ovarian cancer, the company said.
Cyclophosphamide Capsules 25 mg and 50 mg had annual sales of USD 6 million in the US, Zydus Lifesciences said citing IQVIA MAT (moving annual total) October, 2023 data.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 9.80 ( -0.71)
- 44492337
- G V Films
- 0.94 (+ 9.30)
- 37404318
- Jaiprakash Power Ven
- 19.44 ( -3.38)
- 30530141
- Spicejet Ltd.
- 62.79 ( -4.25)
- 22824171
- Srestha Finvest
- 0.89 (+ 4.71)
- 21696619
MORE NEWS
Swiggy Launches 'XL' Fleet for Bulk Orders -...
Swiggy, the IPO-bound food tech platform, launches its 'XL' fleet to cater to bulk...
RBI Deputy Governor Rajeshwar Rao Gets One-Year...
The government has extended the term of RBI Deputy Governor M Rajeshwar Rao for one...
Dev Accelerator Plans Rs 125 Cr IPO for...
Dev Accelerator Ltd, a flexible office space provider, is set to raise Rs 125 crore...